Last update 03 Apr 2025

Darifenacin Hydrobromide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(S)-1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-α,α-diphenyl-3-pyrrolidineacetamide, Darifenacin, Darifenacin hydrobromide (JAN/USAN)
+ [6]
Action
antagonists
Mechanism
M3 receptor antagonists(Muscarinic acetylcholine receptor M3 antagonists)
Therapeutic Areas
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC28H31BrN2O2
InChIKeyUQAVIASOPREUIT-VQIWEWKSSA-N
CAS Registry133099-07-7

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Urinary Bladder, Overactive
United States
22 Dec 2004
Overactive bladder syndrome
European Union
22 Oct 2004
Overactive bladder syndrome
Iceland
22 Oct 2004
Overactive bladder syndrome
Liechtenstein
22 Oct 2004
Overactive bladder syndrome
Norway
22 Oct 2004
Pollakisuria
European Union
22 Oct 2004
Pollakisuria
Iceland
22 Oct 2004
Pollakisuria
Liechtenstein
22 Oct 2004
Pollakisuria
Norway
22 Oct 2004
Urinary Incontinence, Urge
European Union
22 Oct 2004
Urinary Incontinence, Urge
Iceland
22 Oct 2004
Urinary Incontinence, Urge
Liechtenstein
22 Oct 2004
Urinary Incontinence, Urge
Norway
22 Oct 2004
Urinary urgency
European Union
22 Oct 2004
Urinary urgency
Iceland
22 Oct 2004
Urinary urgency
Liechtenstein
22 Oct 2004
Urinary urgency
Norway
22 Oct 2004
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Neurogenic detrusor overactivityPhase 2
United States
07 Oct 2008
Neurogenic detrusor overactivityPhase 2
Colombia
07 Oct 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
35
(Cohort 1 (Darifenacin 0.030 mg/kg/Day))
ycavcatfic(qyhefzfybg) = geljticknd fhshbdkess (odhfjxhbpl, 126.88)
-
09 Jun 2022
(Cohort 2 (Darifenacin 0.0625 mg/kg/Day))
ycavcatfic(qyhefzfybg) = zzgpnmzkpl fhshbdkess (odhfjxhbpl, 104.49)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free